Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 28
- Start-Ups
New Platform Aims to Become ‘Trustpilot for Medical Cannabis’ with Verified Patient Reviews
As incoming European markets look towards alternative delivery mechanisms like oils and vaporisers, more mature markets like the UK remain dominated by traditional dried cannabis flower, representing around 80% of all prescriptions.
- Medical Cannabis
UK’s First Medical Cannabis Legal Helpline Launches as Patients Navigate New Police Guidance
UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate common issues with their medication with professional guidance.
- International Regulation
Is Europe Moving Away From Cannabis Flower?
Spain’s medicines agency has published the first official guidance for medical cannabis preparations, confirming that its incoming market will exclude raw cannabis flower in favour of ‘standardised’ oral solutions prepared exclusively in hospital pharmacies.
- Press releases
KONOPEX Expo 2026 – Celebrating Czech legalization and the freedom to cultivate
It’s here! KONOPEX is once again opening the doors to the world of cannabis – and this time it’s a celebration of a new era and the future of cannabis.
- Investment & Finance
From Courtrooms to Boardrooms: 2026 Consolidation Accelerates as Cannabis Companies Merge, Battle and Partner
The global cannabis industry barely had time to catch its breath over the Christmas break, following several seismic developments at the tail end of the year.
- Patient Access
Seven Years for Progress, Four Days to Undermine It: The UK’s Cannabis Media Storm
On 6 January 2026, the National Police Chiefs’ Council (NPCC) approved the first official guidance on medical cannabis for officers in England and Wales, news that UK patients have been waiting since 2018 to receive.
- International Regulation
France’s First Prescriptions ‘Unlikely This Year’ Despite ‘Complete’ Framework
Last week, France’s now five-year old medical cannabis pilot programme was extended once again, providing a bridge beyond March 2026 for patients to continue secure access to their medication.
- CBD Market
UK CBD Approvals Face Autumn 2026 Crunch as Industry Proposes Framework Overhaul
The UK’s first-ever CBD product authorisations, originally expected to be completed by Autumn 2026, could now face another setback as Food Standards Scotland (FSS) insists on holding its own consultation.
- Medical Cannabis
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated full generalised framework edges towards reality.
- International Regulation
Relm and Prohibition Partners Launch Cannabis Risk Briefing for Emerging and High-Growth Industries
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global report produced in collaboration with Prohibition Partners, the industry-first discovery platform for B2B cannabis.
- UK & Europe
The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s near-billion-euro medical cannabis industry.
- US & Canada
Republican Lawmakers Openly Defy Trump on Cannabis Rescheduling
As the excitement around President Donald Trump’s executive order to push forward with cannabis rescheduling has faded, the bill is now facing a much harsher reality.
